Luminoma is a medical device manufacturer that offers LumAssure, a device that indicates whether a skin lesion is malignant or benign.
Luminoma has raised $2.5M in total funding. The most recent round was Seed. The last funding was announced in January 2024.
Luminoma's investors include Pacific Channel, AngelHQ, Bridgewest Ventures, University of Auckland Inventors Fund.
Luminoma is headquartered in Auckland, New Zealand.
Luminoma is a medical device manufacturer that offers LumAssure, a device that indicates whether a skin lesion is malignant or benign.
Luminoma is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Luminoma — Funding & Investors." VCBacked, January 1, 2024, https://www.vcbacked.co/company/luminoma. Accessed September 12, 2026.
VCBacked. (2024). Luminoma — Funding & Investors. Retrieved September 12, 2026, from https://www.vcbacked.co/company/luminoma
{{cite web |title=Luminoma — Funding & Investors |url=https://www.vcbacked.co/company/luminoma |website=VCBacked |access-date=September 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated